Security Snapshot

VIEMED HEALTHCARE, INC. - Common Shares, No Par Value (VMD) Institutional Ownership

CUSIP: 92663R105

13F Institutional Holders and Ownership History from Q1 2018 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

166

Shares (Excl. Options)

25.55MFull value: 25,548,582 · shares · 30 Jun 2026

Price

$11.40

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Shares, No Par Value
Symbol
VMD on Nasdaq
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
25,548,582
Latest holder snapshot 5 signals
Total 13F value
$291,223,256
Portfolio coverage rank
0%
Share change
+675,062
Value change
+$8,112,208
Number of holders
166
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
38,881,661
SEC-reported price per share
$9.60
Insider filing price
$9.60
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • VMD - VIEMED HEALTHCARE, INC. - Common Shares, No Par Value is tracked under CUSIP 92663R105.
  • 166 institutions reported positions in Q2 2026.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 150 to 166 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $229.23MFull value: $229,232,824 · USD · 31 Mar 2026
    to
    $291.22MFull value: $291,223,256 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 166 institutions filings for Q2 2026.

Open SEC evidence

Security key

92663R105

13F reference period

Q2 2026

13F holders

166

13D/G owners

6

CIK / CUSIP context first

Open Q2 2026 holders VMD full holder history VIEMED HEALTHCARE, INC. SEC filings VIEMED HEALTHCARE, INC. company facts VIEMED HEALTHCARE, INC. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
6
Security
VMD
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
THRIVENT FINANCIAL FOR LUTHERANS 6.8% -22% $18,799,750 -$5,008,816 2,705,000 -21% THRIVENT FINANCIAL FOR LUTHERANS 31 Mar 2025
BlackRock Portfolio Management LLC 6.4% $17,564,888 2,540,114 BlackRock Portfolio Management LLC 30 Jun 2025
Moore Michael 5.9% $20,669,102 2,294,018 Michael Moore 24 Sep 2026
BlackRock, Inc. 5.8% $15,836,715 2,278,664 BlackRock, Inc. 31 Mar 2025
Forager Capital Management, LLC 4.9% -33% $21,510,341 -$9,685,440 1,886,872 -31% Forager Capital Management, LLC 30 Jun 2026
Nantahala Capital Management, LLC 2.9% $7,889,098 1,135,122 Nantahala Capital Management, LLC 30 Sep 2024
As of 30 Jun 2026, 166 institutional investors reported holding
25.55MFull value: 25,548,582 · shares · 30 Jun 2026
shares of VIEMED HEALTHCARE, INC. - Common Shares, No Par Value (VMD). This represents 66% of the company’s total
38.88MFull value: 38,881,661 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
51%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 12% 4,788,307 +3.6% 0% $54,586,700
Forager Capital Management, LLC 5.5% 2,141,184 -24% 9.2% $24,409,498
VANGUARD CAPITAL MANAGEMENT LLC 3.4% 1,321,676 +1.4% 0% $15,067,106
GOLDMAN SACHS GROUP INC 3.1% 1,222,534 -14% 0% $13,936,888
AMERIPRISE FINANCIAL INC 2.6% 1,006,195 +12% 0% $11,470,623
GEODE CAPITAL MANAGEMENT, LLC 2.5% 973,744 +25% 0% $11,102,817
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 2% 786,269 +11% 0% $8,963,467
STATE STREET CORP 2% 762,097 +2.6% 0% $8,687,906
Nantahala Capital Management, LLC 1.6% 632,445 -28% 0.44% $7,209,873
PANAGORA ASSET MANAGEMENT INC 1.4% 538,625 +14% 0.02% $6,140,325
First Eagle Investment Management, LLC 1.4% 535,157 +1% 0.01% $6,100,790
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 1.4% 533,466 -0.72% 0.3% $6,081,512
TWO SIGMA INVESTMENTS, LP 1.1% 438,851 +6.2% 0% $5,002,901
RENAISSANCE TECHNOLOGIES LLC 1.1% 425,900 -3.7% 0.01% $4,855,260
RAFFLES ASSOCIATES LP 1% 403,691 -2.4% 3.9% $4,602,077
ACADIAN ASSET MANAGEMENT LLC 1% 398,586 +141% 0.01% $4,537,000
Creative Planning 0.93% 360,356 +63% 0% $4,108,058
TOCQUEVILLE ASSET MANAGEMENT L.P. 0.88% 342,100 -28% 0.05% $3,899,940
MARTIN & CO INC /TN/ 0.88% 340,771 +25% 0.61% $3,884,789
BARD ASSOCIATES INC 0.87% 339,672 -0.08% 0.86% $3,872,261
MORGAN STANLEY 0.77% 300,410 -7.4% 0% $3,424,673
VANGUARD PORTFOLIO MANAGEMENT LLC 0.72% 281,333 +16% 0% $3,207,196
Penbrook Management LLC 0.71% 277,178 +1.8% 2% $3,159,829
NORTHERN TRUST CORP 0.7% 271,363 +7.9% 0% $3,093,538
LAZARD ASSET MANAGEMENT LLC 0.68% 262,486 +22% 0% $2,992,340

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
33
Headline period
Q2 2026
Rows shown
1-25 of 33
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 1,390,716 $12,658,743 +$1,356,414 $9.10 34
2026 Q2 25,548,582 $291,223,256 +$8,112,208 $11.40 166
2026 Q1 24,888,423 $229,232,824 +$11,846,298 $9.21 150
2025 Q4 23,831,734 $176,976,022 +$2,567,197 $7.43 131
2025 Q3 24,469,425 $166,145,644 -$6,822,607 $6.79 129
2025 Q2 25,382,819 $175,380,483 +$3,214,401 $6.91 125
2025 Q1 24,854,089 $180,942,599 -$968,405 $7.28 138
2024 Q4 25,152,662 $201,731,507 +$494,659 $8.02 140
2024 Q3 25,209,952 $185,528,558 -$2,880,423 $7.33 120
2024 Q2 25,424,128 $166,525,006 +$2,341,353 $6.55 115
2024 Q1 24,742,775 $233,359,136 +$15,812,660 $9.43 110
2023 Q4 23,153,799 $181,860,450 -$2,819,118 $7.85 103
2023 Q3 23,498,774 $158,315,326 +$658,317 $6.73 108
2023 Q2 21,612,357 $211,412,065 +$18,552,064 $9.78 99
2023 Q1 22,327,255 $216,804,458 +$19,491,734 $9.66 88
2022 Q4 20,400,640 $151,789,368 +$14,144,812 $7.56 79
2022 Q3 18,250,089 $109,567,041 -$5,537,971 $6.00 62
2022 Q2 19,271,875 $103,931,514 -$6,869,539 $5.38 69
2022 Q1 21,895,744 $109,358,669 -$2,664,869 $4.98 83
2021 Q4 22,275,292 $116,280,510 -$3,324,259 $5.22 84
2021 Q3 21,412,001 $118,856,841 -$5,047,946 $5.55 76
2021 Q2 22,213,628 $158,888,686 +$5,893,070 $7.15 73
2021 Q1 21,098,814 $213,773,493 +$38,563,847 $10.12 97
2020 Q4 17,403,868 $135,434,917 +$1,660,932 $7.76 94
2020 Q3 17,235,387 $149,253,592 -$8,820,773 $8.64 96
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .